# A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

> **NCT07594522** · PHASE1,PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 36 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **RADIATION:** Photon or Proton standard stereotactic body radiotherapy (SBRT)
- **DRUG:** Ivonescimab

## Key facts

- **NCT ID:** NCT07594522
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-12
- **Primary completion:** 2028-05-12
- **Final completion:** 2028-05-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07594522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07594522, "A Study of Ivonescimab in People With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT07594522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*